Journal of Peptide Science · 2002 · 12 citations · 12 references
PharmacyMedicinal ChemistryPharmacologyComputational ChemistryStructural BiologySynthetic Medicinal ChemistryLigand BindingPeptide ChemistryPeptide Drug DiscoveryProtein-ligand BindingReceptor ModelingReceptor-ligand InteractionsCholecystokinin PharmacologyCoordinationMetal-oxo ComplexesPeptide Medicinal ChemistryPeptide Structure - Activity Relationships
A novel CCK8 derivative bearing a chelating agent at its N- end and its oxo-rhenium(V) complex have been synthesized and characterized. The chelating agent N-[N-13-(diphenylphosphino)propionyl]glycyl]cysteine (PN2S) ligand, the coordination set of which is made by the phosphorus atom of phosphine, the nitrogen atoms of the two amido groups and the sulphur atom of cysteine, has been used due to its high affinity towards the oxo-rhenium(V) moiety. Molecular modelling studies indicate that the CCK8 peptide adopts the right conformation for cholecystokinin receptor binding, and that modifications on the N-terminal side of CCK8 obtained by introducing chelating agents and its metal complexes should not affect the interaction with CCK(A) receptor.
12
Helen M. Berman · Nucleic Acids Research · 2000 · 39.8K citations
Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Jean Claude Reubi, Jean‐Claude Schaer, Beatrice Waser · PubMed · 1997 · 352 citations
Medicine, Oncology, Pharmacology +13
Huiming Guo, Stanley Zucker, Marion K. Gordon et al. · Journal of Biological Chemistry · 1997 · 336 citations · Full text
Medicine, Cell Biology, Oncology +16
Zongshi Ji, Elizabeth M. Hadac, Randel M. Henne et al. · Journal of Biological Chemistry · 1997 · 96 citations · Full text
Medicine, Biochemistry, Pharmacology +17